OneMedNet and Navidence Collaborate to Revolutionize Pharma with Precision Real-World Data Insights

OneMedNet and Navidence have announced a strategic collaboration to help pharmaceutical companies transform healthcare data into actionable real-world evidence. The integration of Navidence's Computable Operational Definitions (CODefs) with OneMedNet's iRWD platform will enable precise definition of health data needs, streamlining study design and regulatory evidence generation. The collaboration aims to reduce mismatches and rework, save costs, and meet regulatory requirements for RWE, particularly valuable in complex fields like precision medicine. The collaboration is intended to advance OneMedNet's life sciences strategy and expand opportunities in the rapidly growing RWD market valued at approximately $1.88 billion in 2025.